SKERLJ RENATO enters X4 PHARMACEUTICALS, INC with 30.41K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/11/2020ACC: 0001628280-20-009291
Officer· Chief Scientific Officer
Since Jun 2020
30.41K
Baseline shares
100% direct
30.41K
Direct ownership
1 position
36.14K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned30.41K
Total
30.41K direct30.41K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 30.41K | Direct |
| Total | 30.41K | 30.41K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
1.14K
Shares owned
N/A
Exercise price
6.84
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
35K
Shares owned
N/A
Exercise price
13.0
Expiration
—
Exercise window
—
Total
Underlying
36.14K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 6.84 | — | — | 1.14K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 13.0 | — | — | 35K | N/A |
| Total | 36.14K | 0.00 | ||||